Progression of Chronic Kidney Disease Risk Categories and Risk of Cardiovascular Disease and Total Mortality: Coronary Artery Risk Development in Young Adults Cohort

被引:11
|
作者
Choi, Yuni [1 ]
Jacobs, David R., Jr. [1 ]
Shroff, Gautam R. [3 ,4 ]
Kramer, Holly [5 ,6 ]
Chang, Alexander R. [7 ]
Duprez, Daniel A. [2 ]
机构
[1] Univ Minnesota, Div Epidemiol & Community Hlth, Sch Publ Hlth, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Cardiovasc Div, Dept Med, 420 Delaware St SE,MMC 508, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Div Cardiol, Hennepin Healthcare, Med Sch, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Dept Med, Hennepin Healthcare, Med Sch, Minneapolis, MN 55455 USA
[5] Loyola Univ Chicago, Dept Publ Hlth Sci, Maywood, IL USA
[6] Loyola Univ Chicago, Dept Med, Maywood, IL USA
[7] Kidney Hlth Res Inst, Div Nephrol, Geisinger Hlth Clin, Danville, PA USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2022年 / 11卷 / 21期
关键词
all-cause mortality; cardiovascular disease; CKD risk categories; KDIGO; progression; transition; young adults; GLOMERULAR-FILTRATION-RATE; ALBUMINURIA; OUTCOMES;
D O I
10.1161/JAHA.122.026685
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Previous studies of worsening chronic kidney disease (CKD) based on declining estimated glomerular filtration rate (eGFR) or increasing urine albumin-creatinine ratio (UACR) are limited to later middle-age and older adults. We examined associations of CKD progression and incident cardiovascular disease (CVD) and mortality in younger adults. Methods and Results We studied 4382 adults in CARDIA (Coronary Artery Risk Development in Young Adults) initially aged 27 to 41 years and prospectively over 20 years. Five-year transition probabilities across CKD risk categories were based on eGFR and UACR measured at each exam. Proportional hazards models predicted incident CVD and all-cause mortality by time-varying CKD risk category, adjusting for demographics and CVD risk factors. Progression of CKD risk categories over 20 years occurred in 28.7% (1256/4382) of participants, driven by increases in UACR, but including 5.8% (n=255) with eGFR<60 mL/min per 1.73 m(2) or UACR >= 300 mg/g. Compared with eGFR >= 60 and UACR <10, demographic and smoking-adjusted hazard ratios for CVD were 1.62 (95% CI, 1.21-2.18) for low CKD risk (eGFR >= 60 with UACR 10-29) and 13.65 (95% CI, 7.52-24.79) for very high CKD risk (eGFR <30 or eGFR 30-44 with UACR 30-299; or eGFR 30-59 with UACR >= 300). Corresponding hazard ratios for all-cause mortality were 1.42 (95% CI, 1.08-1.88) and 14.75 (95% CI, 9.97-21.82). Although CVD associations were attenuated after adjustment for mediating CVD risk factors, all-cause mortality associations remained statistically significant. Conclusions Among young to middle-aged adults, progression to higher CKD risk category was common. Routine monitoring eGFR and UACR holds promise for prevention of CVD and total mortality.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Risk Factors for Coronary Artery Calcium Among Patients With Chronic Kidney Disease (from the Chronic Renal Insufficiency Cohort Study)
    He, Jiang
    Reilly, Muredach
    Yang, Wei
    Chen, Jing
    Go, Alan S.
    Lash, James P.
    Rahman, Mahboob
    DeFilippi, Chris
    Gadegbeku, Crystal
    Kanthety, Radhika
    Tao, Kaixiang
    Hamm, L. Lee
    Ojo, Akinlolu
    Townsend, Ray
    Budoff, Matthew
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (12) : 1735 - 1741
  • [22] Association of Chronic Respiratory Symptoms With Incident Cardiovascular Disease and All-Cause Mortality Findings From the Coronary Artery Risk Development in Young Adults Study
    Feng, Weijing
    Zhang, Zhaoyuan
    Liu, Yu
    Li, Zhibin
    Guo, Wenjie
    Huang, Feifei
    Zhang, Jianwu
    Chen, Ailan
    Ou, Caiwen
    Zhang, Kun
    Chen, Minsheng
    CHEST, 2022, 161 (04) : 1036 - 1045
  • [23] Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacy
    Middleton, John P.
    Pun, Patrick H.
    KIDNEY INTERNATIONAL, 2010, 77 (09) : 753 - 755
  • [24] Arterial stiffness and increased cardiovascular risk in chronic kidney disease
    Ma, Yuxia
    Zhou, Lin
    Dong, Jinghui
    Zhang, Xiaoshen
    Yan, Shi
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (07) : 1157 - 1164
  • [25] Chronic Renal Disease and Risk of Cardiovascular Morbidity-Mortality
    Santoro, Antonio
    Mandreoli, Marcora
    KIDNEY & BLOOD PRESSURE RESEARCH, 2014, 39 (2-3) : 142 - 146
  • [26] Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study
    Bundy, Joshua D.
    Rahman, Mahboob
    Matsushita, Kunihiro
    Jaeger, Byron C.
    Cohen, Jordana B.
    Chen, Jing
    Deo, Rajat
    Dobre, Mirela A.
    Feldman, Harold I.
    Flack, John
    Kallem, Radhakrishna R.
    Lash, James P.
    Seliger, Stephen
    Shafi, Tariq
    Weiner, Shoshana J.
    Wolf, Myles
    Yang, Wei
    Allen, Norrina B.
    Bansal, Nisha
    He, Jiang
    CRIC Study Investigators
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (03): : 601 - 611
  • [27] Should eGFR and Albuminuria Be Added to the Framingham Risk Score? Chronic Kidney Disease and Cardiovascular Disease Risk Prediction
    Chang, Alex
    Kramer, Holly
    NEPHRON CLINICAL PRACTICE, 2011, 119 (02): : C171 - C177
  • [28] Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study
    Di Angelantonio, Emanuele
    Chowdhury, Rajiv
    Sarwar, Nadeem
    Aspelund, Thor
    Danesh, John
    Gudnason, Vilmundur
    BMJ-BRITISH MEDICAL JOURNAL, 2010, 341 : 768
  • [29] Pravastatin and cardiovascular risk in moderate chronic kidney disease
    Nakamura, Haruo
    Mizuno, Kyoichi
    Ohashi, Yasuo
    Yoshida, Tomowo
    Hirao, Koichi
    Uchida, Yasufumi
    ATHEROSCLEROSIS, 2009, 206 (02) : 512 - 517
  • [30] Chronic kidney disease measures for cardiovascular risk prediction
    Mok, Yejin
    Ballew, Shoshana H.
    Matsushita, Kunihiro
    ATHEROSCLEROSIS, 2021, 335 : 110 - 118